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Bioassay guided fractionation of the methanolic extract of the defatt~d Lawsonia inermis see~s
has led to. the isolation of two new triterpenoids lawnermis acid 1 and Its methyl ester la. Their
structures have been established as 3~, 28~-dihydroxy-ursa-12, 20-dien-23a-oic acid 1 and its me-
thyl ester la on the basis of chemical and spectra evidence. Compound 1 shows significant anticom-
plementary activity in vitro tests. It inhibits the irnmunohaemolysis of antibody coated sheep erythro-
cytes by pooled guinea pig serum.
Lawsonia is a monotypic genus represented by
Lawsonia inermis Linn. (Syn. Lawsonia alba
Lam., Lythraceae), a native of North Africa and
South-west Asia, widely cultivated as an ornamen-
tal hedge and dye-plant.
The leaves of L. inermis have long been used 1
in India and Middle East countries as a cosmetic
for colouring palms of hands and dyeing of hair
for personal adornment. They are also used as a
prophylactic in the form of paste or decoction for
the skin inflammation. The essential oil obtained
from the flowers finds use in perfumery due to its
(3-ionone content.
The leaves have been reported to contain var-
ious compounds+' like coumarins, flavonoids, gal-
lic acid, naphthoquinones, naphthalene deriva-
tives, lupane type triterpenoids, aliphatic constitu-
ents, phenolic glycosides and xanthones. Recently,
reports have appeared on the chemical constitu-
ents of the roots" and bark'". However, no report
on the chemical constituents of the seeds except
for its analysis 1 for fatty acids, waxes and colour-
ing matter content and also for biological activity
is available in the literature. Keeping this in view
a systematic study on the non-phenolic constitu-
ents of the seeds of Lawsonia inermis has been
carried. The bioassay guided fractionation has led
to the isolation of a new compound, lawnermis
acid characterised as 3(3, 28(3-dihydroxy-ursa-12,
20-dien-23u-oic acid 1 and its methyl ester la
which are reported in this paper.
Compounds 1 and la were isolated by column
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chromatography followed by flash chromatogra-
phy and preparative TLC. Support for the struc-
ture of the compound 1 occurring as a free car-
boxylic acid (IR: 1692 em -1) and its carboxyme-
thyl ester 1a is evident from the M + peak at m/z
484 for 1a and identical TLC and spectral data
with the compounds obtained by deacetylation of
U-5Ac and U-5AcMe. Further confirmation of
the structure of 1 and la having a basic u-amyrin
skeleton similar to quinovic acid? was obtained by
conversion to the diacetate derivative 1c and car-
boxymethyl diacetate derivative 1b respectively.
Formation of the diacetate 1b the acetoxyl pro-
tons of which appeared in IH NMR at [) 1.91 and
[) 2.10 (s, 2 x OAc) accounted for the presence of
two hydroxyl groups in 1. (3-Configuration of the
C3-OH group was supported by the appearance
of the peak at [) 4.35 (H-3, d, J= 11 Hz) as re-
ported by Kohma and Ogura", The appearance of
the peak at [) 2.2 (d, J= 11 Hz) indicated H-18
belonging to the ursane seriest-". Other signals ap-
peared at [) 3.5 for - OCH3, 3.72, 3.78 (ABq,
J= 11 Hz for C28.CH20H), 1.61 for vinylic me-
thyl", 5.29 and [) 5.30 for the protons of C12-e13
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and C20-C21 double bonds and 0.83, 0.85, 0.95,
1.18 for the remaining methyl groups. The IH
NMR spectral data of 1a further lent support to
structure of 1.
Support for the isolated nature of the double
bond at 1610 cm " and the absence of the gem-
dimethyl doublet at 1385, 1380 cm-1 indicating
substitution of either C-23 or C-24 was obtained
from the IR spectra of all the compounds 1, la,
Ib and Ic, .
In the l3C NMR of Ib (Table I) C3-OH ap-
peared at b 81.0, C20-C21double bond carbons at








































Spectra were recorded in CDCl3 using TMS as internal stand-
ard.






























































136, 120, C2s-CH2-OH at 68.0, C23-OCH3 at
51.0, the two acetate carbonyls at 168.5 and
168.6 and the C-23 carbonyl at <5181.5. The a-
nature of the C-23 was in agreement with the l3C
NMR chemical shift for C-24 at b 14.0 as report-
ed for quinovic acid". The rest of the l3C NMR
peaks for Ib and Ia were in agreement with the
proposed structure.
The mass spectrum of the compound 1b agreed
with the molecular formula C3sH5206 showing the
M+ at mJz 568 (0.5%). Deacetylation of Ib with
KOH gave La which showed M+ at mJz 484
agreeing with the molecular formula C31H4S04'
The presence of two isolated double bonds at
C12-Cl3 and C20-C21 was supported by a double
retro-Diels Alder decomposition of rings 'C' and
'E' (Scheme I) leading to the fragments at mJz
402 (48.2%) indicating presence of - CH20H at
position-28 and the peak at mJz 82 (2%) support-
ed the vinylic methyl at C- 209 and the double
bond at C20-C21, The fragments at mJz 252
(34.1%) and 238 (13.8%) lent further support for
the presence of - COOCH3 at C-4 in ring-A and
those at mJz 272 (34.5%) and 201 (18.1%) for
the substitution of C-28 by - CH20H. All the
combined evidence together led to the establish-
ment of structure 1 as 3~, 28~-dihydroxy-ursa-
12, 20-dien-23a-oic acid and 1a its methyl ester.
Biological assay
The complement system plays an important
role in the host defence system, inflammations or
allergic reactions. Since complement is one of the
major mediators of inflammatory response'v", it
is possible that inhibition of complement activity
would be expected to inhibit inflammatory mol-
dels involving complement activation. The earlier
findings for boswellic acids and oleanolic acid
possessing antiinflammatory and anticomplemen-
tary activities and as inhibitor of Cj-convertase of
classical complement pathway'<" give support to
the mechanism for inhibiting inflammatory reac-
tion .indicating thereby the key role of comple-
ment in inflammation 17.
Keeping this in view the column chroma to-
graphed fractions of L. inermis were screened for
their anti-complementary activity as compared
with aspirin which served as standard (Table IT).
The marked action of the compound as well as
that of the fraction yielding these compounds was
found to be 100 ug (100 1lg/0.1 mL diluent). A
maximum inhibitory effect of 91% on haemolytic
activity of complement system towards antibody
coated sheep erythrocytes induced by freshly
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mlz 270 (b.p. 100 )
1b 1M+at mlz 568 ( 0.5% ) -2H
1-42 -2H~-";::+ ~1l+
m/z 526(90%) - + 7!-42 H . I CH20COCH3
COOCH3
m/z 252 (31.4 %) mlz 272 (34.5% )
i-CH2 -71
m/z 238 ( 13.8% )
mlz 82 (2%)0
COOC!"i3
mlz 402 ( 48.2 % )
1-14 *
mlz 388 (80%)
m/z 470 ( 5.6% ) -14 m/z 484 ( 2.4% )
(Also 1a,M+ 484 )












Control 1.347 ± 0.004
la 1.333 ± 0.003 1.03
1 0.118 ± 0.005 91.23
Aspirin 0.450 ± 0.010 66.59
The data are the mean ± SD of triplicate determinations from
three experiments.
pooled guinea pig serum was observed in com-
pound 1. Thus anticomplementary activity com-
pounds can be used i.J;J. the therapy of inflamm-
ations and other disorders associated with com-
plement activation.
Experimental Section
IR spectra were recorded on a PC-16 FI
Perkin-Elmer or Hitachi 270-30 spectrometer, 'H
NMR spectra on a PMX 60-S1 and Bruker AC-
P400 spectrometer with TMS as internal stand-
ard, 13C NMR spectra on a FfNMR-FX-90Q
multinuclear machine and GC-MS spectra on a
+
mlz 119 ( 7.2% ) mlz 201 (18.1%)
Scheme I
Shimadzo GP 2000 spectrometer. For bioassay
Perkin-Elmer UVIVIS spectrophotometer Lamb-
da 3~ and for flash chromatography Eyela EF-lO
flash chromatography were used.
Plant material. The seeds of Lawsonia inermis
were identified and supplied by Dr T N Srivasta-
va of the Botany Division of the Laboratory.
Extraction and isolation. The air-dried coarsely
powdered and defatted L. inermis seeds (10 kg)
on extraction with methanol in a soxhlet yielded
an extract (1.8 kg) showing about 68% activity.
The extract was treated with water (6L) and n-
~uOH (6L) to give an inactive CHCl3 extract (10
g) and 90% active n-~uOH extract (90 gm). The
n-~uOH extract was treated with 3% Na2C03 so-
lution (4.5 L) and extracted with CHCl3 to give
an unsaponifiable fraction (168 g) exhibiting about
90% activity. The saponified aqueous alkaline ex-
tract was acidified with dil. HCl and extracted
with CHCl3 to yield a saponified fraction (320 g).
A part of the unsaponifiable fraction (40 g) was
charged over a column (90 x 5.5 ern) of silica gel
(230-400 mesh: 100 g and 60-120 mesh: 350 g)
and eluted with petrol (60-80°), C6H6, EtOAc and
their mixtures collecting in all 300 fractions of
250 mL each. Fraction 1-10 yielded a compound
U-1 (m.p. 78-80°), 31-40 (petrol: 90-C6H6: 10),
U-2 (m.p. 65-70°), 201-207 (C6H6: 95-EtOAc:
HANDA et aL:LAWNERMIS ACID FROM LAWSONIA INERMIS SEEDS
5); U-3 (m.p. 220-266), 208-215 (C6H6: 45:
EtOAc: 5), U-4 (m.p. 160-70°) and 261-95
(C6H6:80-EtOAc: 20), U-5 (m.p. 190-260°: 2.5
g a mixture of three compounds). The residue
U-5 (2.0 g) on flash chromatography over silica
gel (200 g: 230-400 mesh) collecting in all 70
fractions each of 10 mL using hexane and hexane:
EtOAc mixture yielded on evaporation from frac-
tions 57-59 (hexane-EtOAc 60:40) a dark brown
viscous residue (180 mg) which was a mixture of
two compounds. This on preparative 1LC (C6H6-
CHCI3-MeOH 70:10:1) yielded U-5A (1, 60 mg)
which showed 90% biological activity. IR (KBr):
3420 (- OH), 2936, 2870, 1696 (- COOH),
1610 (double bond), 1392, 1385, 1280, 1186,
1056 and 1040 cm-I; no M+ peak at mJz 470
but other peaks at mJz 380, 379 (b.p.), 378,
119,82, 58 and the other inactive compounds U-
5B, (la, 40 mg); IR (KBr): 3418 (- OH), 2936,
2870, 1725, 1610 (double bond), 1466 (ether lin-
kage), 1390, 1385, 1280, 1185, 1058 and 1040
cm-I; M+ at mJz 484 and other peaks at mJz
470, 426, 412, 398, 388, 252, 235, 119, 101, 83,
82 (b.p.)58 and 43.
Acetylation of U-S. The compound U-5 (500
mg) was treated with acetic anhydride (4.0 mL)
and pyridine (2mL). The mixture was kept at
room temperature for 24 hr, then heated on a
water-bath for 1 hr, and worked up in usual man-
ner yielding the acetate U-5Ac, m.p. 200-40°, a
mixture of two compounds 1b and 1c.
Methylation of U-SAc. The acetyl derivative
U-5Ac (200 mg) obtained above was methylated
with diazomethane and the reaction mixture was
worked up as usual to yield a compound U-
5AcMe ester Ib which crystallised from EtOAc-
MeOH, m.p. 145-50°, [a]i,8+0.003 (0.3 CHCI3);
IR (KBr): 2934, 2850, 1730, 1610, 1450, 1368,
1200 and 1054 cm-I; IHNMR (CDCl3 40-0
MHz): f) 0.6 (3H, s), 0.83 (3H, d), 0.85 (3H, s),
0.95 (3H, s), 1.18 (3H, s), 1.63 (3H, s), 1.91 and
2.10 (2 xOAc, s), 2.2 (IH, br d, J= 11 Hz), 3.40
(3H, s), 3.72, 3.78 (2H, ABq, J = 11 Hz), 4.35
(IH, d, J= 11 Hz), 5.24 and 5.30 (2H, br, d); 13C
NMR (Table I); MS: (eV-70): M+ at mJz 568
(0.5%) and other peaks appeared at mJz 526
(90%), 484 (2.4), 470 (5.6), 454 (13.6), 402
(48.2%), 379 (0.4), 272 (34.2), 271 (86.6), 270
(b.p. 100%), 268 (68.5), 254 (15.2), 252 (34.1),
251 (10.7), 250 (16.4), 238 (13.8), 235 (95.5),
233 (56.4), 219 (61.2), 217 (32.1), 203 (42.4), 201
(19.1), 187 (33.0), 185 (20.5), 167 (2.0), 166 (4.0),
165 (3.0), 121 (0.3), 119 (7.2), 118 (7.0), 83 (6.0),
82 (2.0), 71 (1.5),59 (0.8), 58 (30.0),44 (7.9) and
43 (99.0).
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Deacetylation. of U-5AcMe (lb) to U-5B (la):
The methylated acetate U-5AcMe (Ib) obtained
above was deacetylated by refluxing on a water
bath with 4% methanolic KOH and the reaction'
mixture was worked up as usual to yield the
methylated derivative, U-5Me la [a]i,6+ 33
(CHCl3, c, 0.6); IR (KBr): 3420 (- OH), 2932,
2860, 1730 (ester), 1610 (double bond), 1465,
1460, 1380, 1360, 1264, 1240, 1200, 1040,
1030, 800 and 760 cm-I; IH NMR (CDCI3, 400
MHz): f). 0.80 (s x 2 x CH3), 1.18, 1.20, 1.25
(3 x CH3), 1.60 (s, CH3), 2.20 (IH, d, J= 11 Hz),
3.5 (s, OCH3), 4.08, 4.15 (24, ABq, J= 11Hz), 4.4
(d, IH, J= 11 Hz), 5.1, 5.2 (d, 2H). This product
was found to be identical (1LC, IR, 13CNMR)
with the compound U-5 (la).
Deacetylation of U-SAc. Deacetylation of U-
5Ac (100 mg) was conducted as above giving a
mixture of 2 spots on TLC corresponding to U-
5A (1) and U-5B (La), The IR spectrum of the
mixture exhibited a band at 1696 em- I due to the
carboxylic group of the compound 1.
Bioassay. The in vitro haemolysing effect of the
compounds 1 and La (Table II) vis the classical
pathway was determined by Hart methodt--P. The
veronal saline buffer (pH 7.3) was used as diluent
in complement assay and fresh pooled guinea pig
serum as a source of complement. Sensitized
sheep erythrocytes were incubated with comple- I
ment incubated fractions. Simultaneously standard
drug like aspirin as well as controls were also run.
The degree of haemolysis produced by released
haemoglobin in the supernatant after sedimenta-
tion of the remaining erythrocytes was determined
spectrophotometrically at 413 nm.
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